表紙
市場調查報告書
商品編碼
1069405

糖尿病治療設備的全球市場:現狀分析與預測(2021年∼2027年)

Diabetes Care Devices Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 248 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球糖尿病治療設備的市場規模,在預測期間(2021年∼2027年)預計將以約6%的年複合成長率成長。

人類胰島素輸送系統的進步、胰島素輸送系統技術的創新、報銷政策以及公眾對糖尿病管理意識的提高是推動市場增長的因素。

本報告提供全球糖尿病治療設備市場的相關調查,提供市場摘要,市場洞察,市場機會,競爭模式,企業概要等全面性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 限制
  • 相關利益者
  • 報告所使用的貨幣

第2章 調查手法或假設

  • 糖尿病治療設備市場調查流程
  • 糖尿病治療設備市場調查手法
  • 預測方法
  • 受訪者簡介
  • 糖尿病治療設備市場調查的主要目的

第3章 市場摘要

第4章 摘要整理

第5章 糖尿病治療設備市場COVID-19影響

第6章 糖尿病治療設備市場收益(2019年∼2027年)

第7章 市場洞察:各類型

  • 監測設備
    • 血糖的自我監測
    • 葡萄糖的繼續監測
  • 管理設備
    • 胰島素幫浦
    • 胰島素注射器
    • 胰島素濾芯
    • 拋棄式筆
    • 噴射注射器

第8章 市場洞察:各終端用戶

  • 患者/居家醫療
  • 醫院和診所

第9章 市場洞察:各地區

  • 北美的糖尿病治療設備市場
    • 美國
    • 加拿大
    • 其他的北美
  • 歐洲的糖尿病治療設備市場
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區的糖尿病治療設備市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他的亞太地區
  • 其他

第10章 糖尿病治療設備市場市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第11章 糖尿病治療設備市場機會

第12章 糖尿病治療設備的市場趨勢

第13章 糖尿病治療設備和法律規範

第14章 需求與供給面的分析

  • 需求面分析
  • 供給面分析

第15章 價值鏈分析

第16章 競爭模式

  • 競爭情形
    • 企業佔有率:各收益

第17章 企業概要

  • Medtronic
  • DexCom, Inc.
  • F. Hoffmann-La Roche AG
  • Novo Nordisk A/S
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Tandem Diabetes are, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG

第18章 免責聲明

目錄
Product Code: UMHE21683

Diabetes Care Devices Market is expected to grow at a CAGR of around 6% over the forecast period (2021-2027). The rise of this market is fueled by a growing diabetic population, obesity, and a sedentary lifestyle. Furthermore, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, as well as rising awareness among the population about diabetes control and accessibility to insulin delivery systems, are all factors ensuring the market's growth.

Several government organizations are focusing on boosting the existing infrastructure for overall healthcare system development. Among the countries worldwide, the United States had the highest percentage of gross domestic product spent on health care in 2019. The U.S. spent nearly 17% of its GDP on health care services. Germany, Switzerland, and France followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries.

The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.

Some of the major players operating in the market include: Medtronic, DexCom, Inc., F. Hoffmann-La Roche AG, Novo Nordisk A/S, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Tandem Diabetes are, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

"Amongst Type, Insulin Pens segment dominated the market in 2020"

Based on Type, the market is segmented into Devices (Self-monitoring Blood Glucose (Glucometer Devices, Test Strips, Lancets), Continuous Glucose Monitoring (Sensors, Durables), Management Devices [Insulin Pumps (Insulin Pump Device, Insulin Pump Reservoir), Infusion Set, Insulin Syringes, Insulin Cartridges, Disposable Pens, Jet Injectors. The Monitoring Devices segment leads the Diabetes Care Devices Market. Insulin pens are growing in popularity, and many people with diabetes nowadays use home-based glucose monitoring devices to keep check on their diabetes readings.

"Amongst End-User, Patients/Homecare segment dominated the market in 2020."

Based on End-User, the Diabetes Care Devices market is segmented into Patients/Homecare and Hospitals & Clinics. The patients/homecare segment commanded the largest share of the diabetes care devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.

"North America represents as the largest market."

For a better understanding of the market adoption of Diabetes Care Devices, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. Asia-Pacific dominated the market in 2020. North America dominated the market. The rising prevalence of diabetes and favorable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this region's large share.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional & country-level analysis of the industry

Customization Options:

Diabetes Care Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Diabetes Care Devices Market
  • 2.2. Research Methodology of the Diabetes Care Devices Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Diabetes Care Devices Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 DIABETES CARE DEVICES MARKET COVID-19 IMPACT

6 DIABETES CARE DEVICES MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Monitoring Devices
    • 7.1.1. Self-monitoring Blood Glucose
      • 7.1.1.1. Glucometer Devices
      • 7.1.1.2. Test Strips
      • 7.1.1.3. Lancets
    • 7.1.2. Continuous Glucose Monitoring
      • 7.1.2.1. Sensors
      • 7.1.2.2. Durables
  • 7.2. Management Devices
    • 7.2.1. Insulin Pumps
      • 7.2.1.1. Insulin Pump Device
      • 7.2.1.2. Insulin Pump Reservoir
      • 7.2.1.3. Infusion Set
    • 7.2.2. Insulin Syringes
    • 7.2.3. Insulin Cartridges
    • 7.2.4. Disposable Pens
    • 7.2.5. Jet Injectors

8 MARKET INSIGHTS BY END-USER

  • 8.1. Patients/Homecare
  • 8.2. Hospitals & Clinics

9 MARKET INSIGHTS BY REGION

  • 9.1. NORTH AMERICA DIABETES CARE DEVICES MARKET
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. EUROPE DIABETES CARE DEVICES MARKET
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. United Kingdom
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. ASIA-PACIFIC DIABETES CARE DEVICES MARKET
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. Rest of Asia Pacific
  • 9.4. REST OF WORLD DIABETES CARE DEVICES MARKET

10 DIABETES CARE DEVICES MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 DIABETES CARE DEVICES MARKET OPPORTUNITIES

12 DIABETES CARE DEVICES MARKET TRENDS

13 DIABETES CARE DEVICES & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. COMPETITIVE LANDSCAPE
    • 16.1.1. Company Shares, By Revenue

17 COMPANY PROFILED

  • 17.1. Medtronic
  • 17.2. DexCom, Inc.
  • 17.3. F. Hoffmann-La Roche AG
  • 17.4. Novo Nordisk A/S
  • 17.5. Johnson & Johnson
  • 17.6. Abbott Laboratories
  • 17.7. Becton, Dickinson and Company
  • 17.8. Tandem Diabetes are, Inc.
  • 17.9. Ascensia Diabetes Care Holdings AG
  • 17.10. B. Braun Melsungen AG

18 DISCLAIMER